메뉴 건너뛰기




Volumn 29, Issue 3, 2011, Pages 333-338

Management of patients with hepatocellular carcinoma and extrahepatic metastasis

Author keywords

Bone metastasis; Extrahepatic metastasis; Hepatocellular carcinoma; Locoregional therapy; Multidisciplinary approach; Pulmonary metastasis; Sorafenib; Systemic chemotherapy; Targeted therapy

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; SORAFENIB; TOPOTECAN;

EID: 80051717035     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000327572     Document Type: Conference Paper
Times cited : (33)

References (30)
  • 1
    • 51649125242 scopus 로고    scopus 로고
    • Extrahepatic metastasis of hepatocellular carcinoma: Incidence and risk factors
    • Kanda M, Tateishi R, Yoshida H, et al: Extrahepatic metastasis of hepatocellular carcinoma: Incidence and risk factors. Liver Int 2008; 28: 1256-1263.
    • (2008) Liver Int , vol.28 , pp. 1256-1263
    • Kanda, M.1    Tateishi, R.2    Yoshida, H.3
  • 5
    • 0038052657 scopus 로고    scopus 로고
    • Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis
    • Lin SC, Shih SC, Kao CR, et al: Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis. World J Gastroenterol 2003; 9: 1208-1211.
    • (2003) World J Gastroenterol , vol.9 , pp. 1208-1211
    • Lin, S.C.1    Shih, S.C.2    Kao, C.R.3
  • 7
    • 3042777392 scopus 로고    scopus 로고
    • Systemic treatment and liver transplantation for hepatocellular carcinoma: Two ends of the therapeutic spectrum
    • DOI 10.1016/S1470-2045(04)01508-6, PII S1470204504015086
    • Burroughs A, Hochhauser D, Meyer T: Systemic treatment and liver transplantation for hepatocellular carcinoma: Two ends of the therapeutic spectrum. Lancet Oncol 2004; 5: 409-418. (Pubitemid 38878044)
    • (2004) Lancet Oncology , vol.5 , Issue.7 , pp. 409-418
    • Burroughs, A.1    Hochhauser, D.2    Meyer, T.3
  • 10
    • 53749103405 scopus 로고    scopus 로고
    • Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy
    • Ferrari D, Di Maria G, Fazio N, et al: Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy. Anticancer Drugs 2008; 19: 837-840.
    • (2008) Anticancer Drugs , vol.19 , pp. 837-840
    • Ferrari, D.1    Di Maria, G.2    Fazio, N.3
  • 11
    • 63649164307 scopus 로고    scopus 로고
    • Successful treatment of pulmonary metastases associated with advanced hepatocellular carcinoma by systemic 5-fluorouracil combined with interferon-α in a hemodialysis patient
    • Katamura Y, Aikata H, Kimura Y, et al: Successful treatment of pulmonary metastases associated with advanced hepatocellular carcinoma by systemic 5-fluorouracil combined with interferon-α in a hemodialysis patient. Hepatol Res 2009; 39: 415-420.
    • (2009) Hepatol Res , vol.39 , pp. 415-420
    • Katamura, Y.1    Aikata, H.2    Kimura, Y.3
  • 12
    • 47949116252 scopus 로고    scopus 로고
    • Sorafenib in advanced hepatocellular carcinoma
    • Llovet JM, Ricci S, Mazzaferro V, et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390.
    • (2008) N Engl J Med , vol.359 , pp. 378-390
    • Llovet, J.M.1    Ricci, S.2    Mazzaferro, V.3
  • 13
    • 0037129704 scopus 로고    scopus 로고
    • Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial
    • DOI 10.1016/S0140-6736(02)08649-X
    • Llovet JM, Real MI, Montana X, et al: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet 2002; 359: 1734-1739. (Pubitemid 34607087)
    • (2002) Lancet , vol.359 , Issue.9319 , pp. 1734-1739
    • Llovet, J.M.1    Real, M.I.2    Montana, X.3    Planas, R.4    Coll, S.5    Aponte, J.6    Ayuso, C.7    Sala, M.8    Muchart, J.9    Sola, R.10    Rodes, J.11    Bruix, J.12
  • 14
    • 0036237822 scopus 로고    scopus 로고
    • Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma
    • DOI 10.1053/jhep.2002.33156
    • Lo CM, Ngan H, Tso WK, et al: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171. (Pubitemid 34454013)
    • (2002) Hepatology , vol.35 , Issue.5 , pp. 1164-1171
    • Lo, C.-M.1    Ngan, H.2    Tso, W.-K.3    Liu, C.-L.4    Lam, C.-M.5    Poon, R.T.-P.6    Fan, S.-T.7    Wong, J.8
  • 16
    • 0032879468 scopus 로고    scopus 로고
    • Prognosis of hepatocellular carcinoma the BCLC staging classification
    • Llovet JM, Brú C, Bruix J: Prognosis of hepatocellular carcinoma the BCLC staging classification. Semin Liver Dis 1999; 19: 329-338.
    • (1999) Semin Liver Dis , vol.19 , pp. 329-338
    • Llovet, J.M.1    Brú, C.2    Bruix, J.3
  • 17
    • 63049099301 scopus 로고    scopus 로고
    • Systemic treatment in hepatocellular carcinoma: 'a small step for man...'
    • Witjes CD, Verhoef C, Verheul HM, et al: Systemic treatment in hepatocellular carcinoma: 'a small step for man...'. Neth J Med 2009; 67: 86-90.
    • (2009) Neth J Med , vol.67 , pp. 86-90
    • Witjes, C.D.1    Verhoef, C.2    Verheul, H.M.3
  • 18
    • 57749189578 scopus 로고    scopus 로고
    • Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial
    • Cheng AL, Kang YK, Chen Z, et al: Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009; 10: 25-34.
    • (2009) Lancet Oncol , vol.10 , pp. 25-34
    • Cheng, A.L.1    Kang, Y.K.2    Chen, Z.3
  • 19
    • 65349096880 scopus 로고    scopus 로고
    • Selection of patients with hepatocellulacr carcinoma for sorafenib
    • Abou-Alfa GK: Selection of patients with hepatocellulacr carcinoma for sorafenib. J Natl Compr Canc Netw 2009; 7: 397-403.
    • (2009) J Natl Compr Canc Netw , vol.7 , pp. 397-403
    • Abou-Alfa, G.K.1
  • 20
    • 59449089100 scopus 로고    scopus 로고
    • Phase 2 openlabel study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: Presence of lung metastasis predicts poor response
    • Yau T, Chan P, Ng KK, et al: Phase 2 openlabel study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: Presence of lung metastasis predicts poor response. Cancer 2009; 115: 428-436.
    • (2009) Cancer , vol.115 , pp. 428-436
    • Yau, T.1    Chan, P.2    Ng, K.K.3
  • 21
    • 60849136064 scopus 로고    scopus 로고
    • Combined approach to hepatocellular carcinoma: A new treatment concept for nonresectable disease
    • Strebel BM, Dufour JF: Combined approach to hepatocellular carcinoma: A new treatment concept for nonresectable disease. Expert Rev Anticancer Ther 2008; 8: 1743-1749.
    • (2008) Expert Rev Anticancer Ther , vol.8 , pp. 1743-1749
    • Strebel, B.M.1    Dufour, J.F.2
  • 23
    • 0031691340 scopus 로고    scopus 로고
    • Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma
    • Lam CM, Lo CM, Yuen WK, et al: Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg 1998; 85: 1198-200.
    • (1998) Br J Surg , vol.85 , pp. 1198-200
    • Lam, C.M.1    Lo, C.M.2    Yuen, W.K.3
  • 24
    • 3343021898 scopus 로고    scopus 로고
    • Longterm survival after pulmonary metastatectomy of hepatocellular carcinoma; treatment outcome or natural history?
    • Gwak GY, Jung JO, Sung SW, et al: Longterm survival after pulmonary metastatectomy of hepatocellular carcinoma; treatment outcome or natural history? Hepatogastroenterology 2004; 51: 1428-1433.
    • (2004) Hepatogastroenterology , vol.51 , pp. 1428-1433
    • Gwak, G.Y.1    Jung, J.O.2    Sung, S.W.3
  • 26
    • 51649096448 scopus 로고    scopus 로고
    • Metastatic hepatocellular carcinoma: When how where and so what?
    • Huo TI, Lin HC: Metastatic hepatocellular carcinoma: When, how, where and so what? Liver Int 2008; 28: 1183-1185.
    • (2008) Liver Int , vol.28 , pp. 1183-1185
    • Huo, T.I.1    Lin, H.C.2
  • 27
    • 17044372426 scopus 로고    scopus 로고
    • Radiotherapy for painful bone metastases from hepatocellular carcinoma
    • Seong J, Koom WS, Park HC: Radiotherapy for painful bone metastases from hepatocellular carcinoma. Liver Int 2005; 25: 261-265.
    • (2005) Liver Int , vol.25 , pp. 261-265
    • Seong, J.1    Koom, W.S.2    Park, H.C.3
  • 29
    • 3142663128 scopus 로고    scopus 로고
    • Intracranial metastasis of hepatocellular carcinoma: Review of 45 cases
    • DOI 10.1016/j.surneu.2003.10.002, PII S009030190300716X
    • Chang L, Chen YL, Kao MC: Intracranial metastasis of hepatocellular carcinoma: Review of 45 cases. Surg Neurol 2004; 62: 172-177. (Pubitemid 38917099)
    • (2004) Surgical Neurology , vol.62 , Issue.2 , pp. 172-177
    • Chang, L.1    Chen, Y.-L.2    Kao, M.-C.3
  • 30
    • 0029119769 scopus 로고
    • Clinical and radiological pictures of hepatocellular carcinoma with intracranial metastasis
    • Yen FS, Wu JC, Lai CR, et al: Clinical and radiological pictures of hepatocellular carcinoma with intracranial metastasis. J Gastroenterol Hepatol 1995; 10: 413-418.
    • (1995) J Gastroenterol Hepatol , vol.10 , pp. 413-418
    • Yen, F.S.1    Wu, J.C.2    Lai, C.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.